A PROspective Randomised Double-Blind Parallel Group Placebo Controlled Multicentre Trial Of Faecal Microbiota TransSplantation To Improve The Primary OutcomE (First Hospitalisation Due To Infection) In Patients with Cirrhosis Over 24 Months (PROMISE) - Joint with KCL & King's College Hospital NHS Foundation Trust (NRS22_1004822)